332 related articles for article (PubMed ID: 15501397)
1. Abnormal expression of chemokine receptors in Behçet's disease: relationship to intracellular Th1/Th2 cytokines and to clinical manifestations.
Houman H; Hamzaoui A; Ben Ghorbal I; Khanfir M; Feki M; Hamzaoui K
J Autoimmun; 2004 Nov; 23(3):267-73. PubMed ID: 15501397
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of the chemokine receptors by the Th1- and Th2-type effector populations within circulating CD4+ T cells.
Yamamoto J; Adachi Y; Onoue Y; Adachi YS; Okabe Y; Itazawa T; Toyoda M; Seki T; Morohashi M; Matsushima K; Miyawaki T
J Leukoc Biol; 2000 Oct; 68(4):568-74. PubMed ID: 11037980
[TBL] [Abstract][Full Text] [Related]
3. Divergent cytokine production profile in Behçet's disease. Altered Th1/Th2 cell cytokine pattern.
Raziuddin S; al-Dalaan A; Bahabri S; Siraj AK; al-Sedairy S
J Rheumatol; 1998 Feb; 25(2):329-33. PubMed ID: 9489829
[TBL] [Abstract][Full Text] [Related]
4. Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis.
Caproni M; Torchia D; Schincaglia E; Volpi W; Frezzolini A; Schena D; Marzano A; Quaglino P; De Simone C; Parodi A; Barletta E; Fabbri P
Br J Dermatol; 2006 Oct; 155(4):722-8. PubMed ID: 16965421
[TBL] [Abstract][Full Text] [Related]
5. Increased frequencies of interleukin-2- and interferon-gamma-producing T cells in patients with active Behçet's disease.
Sugi-Ikai N; Nakazawa M; Nakamura S; Ohno S; Minami M
Invest Ophthalmol Vis Sci; 1998 May; 39(6):996-1004. PubMed ID: 9579479
[TBL] [Abstract][Full Text] [Related]
6. Increased entry of CD4+ T cells into the Th1 cytokine effector pathway during T-cell division following stimulation in Behcet's disease.
Koarada S; Haruta Y; Tada Y; Ushiyama O; Morito F; Ohta A; Nagasawa K
Rheumatology (Oxford); 2004 Jul; 43(7):843-51. PubMed ID: 15150429
[TBL] [Abstract][Full Text] [Related]
7. Tc1/Tc2 ratio in the inflammatory process in patients with Behçet's disease.
Houman H; Hamzaoui A; Ben Ghorbal I; Khanfir MS; Feki M; Hamzaoui K
Mediators Inflamm; 2004 Aug; 13(4):247-53. PubMed ID: 15545055
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of CXCR6 and CXCR3 in lymphocytes from birch-allergic patients.
Casas R; Lindau C; Zetterström O; Duchén K
Scand J Immunol; 2008 Sep; 68(3):351-61. PubMed ID: 18782262
[TBL] [Abstract][Full Text] [Related]
9. Th1 polarization of the immune response in Behçet's disease: a putative pathogenetic role of interleukin-12.
Frassanito MA; Dammacco R; Cafforio P; Dammacco F
Arthritis Rheum; 1999 Sep; 42(9):1967-74. PubMed ID: 10513814
[TBL] [Abstract][Full Text] [Related]
10. Sustained T-bet expression confers polarized human TH2 cells with TH1-like cytokine production and migratory capacities.
Lametschwandtner G; Biedermann T; Schwärzler C; Günther C; Kund J; Fassl S; Hinteregger S; Carballido-Perrig N; Szabo SJ; Glimcher LH; Carballido JM
J Allergy Clin Immunol; 2004 May; 113(5):987-94. PubMed ID: 15131585
[TBL] [Abstract][Full Text] [Related]
11. Cytokine and chemokine expression in the skin from patients with maculopapular exanthema to drugs.
Fernandez TD; Mayorga C; Torres MJ; Cornejo-Garcia JA; López S; Chaves P; Rondon C; Blanca M
Allergy; 2008 Jun; 63(6):712-9. PubMed ID: 18384452
[TBL] [Abstract][Full Text] [Related]
12. Expression of a splice variant of CXCR3 in Crohn's disease patients; indication for a lymphocyte--epithelial cell interaction.
Manousou P; Kolios G; Drygiannakis I; Pyrovolaki K; Bourikas L; Papadaki HA; Kouroumalis E
J Gastroenterol Hepatol; 2008 Dec; 23(12):1823-33. PubMed ID: 18761554
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of fluvastatin on cytokine and chemokine production by peripheral blood mononuclear cells in patients with allergic asthma.
Samson KT; Minoguchi K; Tanaka A; Oda N; Yokoe T; Yamamoto Y; Yamamoto M; Ohta S; Adachi M
Clin Exp Allergy; 2006 Apr; 36(4):475-82. PubMed ID: 16630152
[TBL] [Abstract][Full Text] [Related]
14. Skewing of cytotoxic activity and chemokine production, but not of chemokine receptor expression, in human type-1/-2 gamma delta T lymphocytes.
Dagna L; Iellem A; Biswas P; Resta D; Tantardini F; Fortis C; Sabbadini MG; D'Ambrosio D; Manfredi AA; Ferrarini M
Eur J Immunol; 2002 Oct; 32(10):2934-43. PubMed ID: 12355447
[TBL] [Abstract][Full Text] [Related]
15. Expression and role of CCR6/CCL20 chemokine axis in pulmonary sarcoidosis.
Facco M; Baesso I; Miorin M; Bortoli M; Cabrelle A; Boscaro E; Gurrieri C; Trentin L; Zambello R; Calabrese F; Cassatella MA; Semenzato G; Agostini C
J Leukoc Biol; 2007 Oct; 82(4):946-55. PubMed ID: 17615381
[TBL] [Abstract][Full Text] [Related]
16. Induction of surface CCR4 and its functionality in mouse Th2 cells is regulated differently during Th2 development.
Morimoto Y; Bian Y; Gao P; Yashiro-Ohtani Y; Zhou XY; Ono S; Nakahara H; Kogo M; Hamaoka T; Fujiwara H
J Leukoc Biol; 2005 Sep; 78(3):753-61. PubMed ID: 16126843
[TBL] [Abstract][Full Text] [Related]
17. CXCR3-mediated opposite effects of CXCL10 and CXCL4 on TH1 or TH2 cytokine production.
Romagnani P; Maggi L; Mazzinghi B; Cosmi L; Lasagni L; Liotta F; Lazzeri E; Angeli R; Rotondi M; Filì L; Parronchi P; Serio M; Maggi E; Romagnani S; Annunziato F
J Allergy Clin Immunol; 2005 Dec; 116(6):1372-9. PubMed ID: 16337473
[TBL] [Abstract][Full Text] [Related]
18. Nickel-responding T cells are CD4+ CLA+ CD45RO+ and express chemokine receptors CXCR3, CCR4 and CCR10.
Moed H; Boorsma DM; Stoof TJ; von Blomberg BM; Bruynzeel DP; Scheper RJ; Gibbs S; Rustemeyer T
Br J Dermatol; 2004 Jul; 151(1):32-41. PubMed ID: 15270870
[TBL] [Abstract][Full Text] [Related]
19. Functional lymphocyte subset assessment of the Th1/Th2 profile in patients with autoimmune thyroiditis by flowcytometric analysis of peripheral lymphocytes.
Colin IM; Isaac J; Dupret P; Ledant T; D'Hautcourt JL
J Biol Regul Homeost Agents; 2004; 18(1):72-6. PubMed ID: 15323363
[TBL] [Abstract][Full Text] [Related]
20. Chemotactic mediators of Th1 T-cell trafficking in smokers and COPD patients.
Brozyna S; Ahern J; Hodge G; Nairn J; Holmes M; Reynolds PN; Hodge S
COPD; 2009 Feb; 6(1):4-16. PubMed ID: 19229703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
